Digital Healthcare Track
Moderator: Moshe Klaiman, CEO, Matrix Medika
11:20 - 11:40
How Difficult is it to Bring a Digital Health Product to the World?
What are the difficulties on the way? What would I ask myself before and during? - The life cycle of a digital health company and product - from the drawing board to the CYBER challenges in clinical/commercial use.
With over 20 years of experience in development, management and R&D in the healthcare industry, Moshe founded Medika (now part of Matrix) to deliver high-end projects, systems, and domain expertise to cutting-edge medical device and digital healthcare companies. Under Moshe’s leadership, Medika has made a name for itself by taking on the regulation, cybersecurity, and development challenges unique to the industry.
11:40 - 12:00
Dermatology Digital Health - Idea to Growth
Suzanne Levy Friedman
12:00 - 12:20
New FDA Guidance Means that Your Previously Exempted Software May Now Be Regulated by FDA
FDA recently issued its long-awaited final guidance document on the regulation of “clinical decision support” (CDS) software – tools that assist clinicians by analyzing patient data and generating corresponding notifications or recommendations. FDA has added significant nuance to the criteria for qualifying as non-device CDS, which results in extending FDA’s authority over more CDS products. This poses challenges for industry with currently marketed products that have historically not been actively regulated by FDA. This talk will focus on FDA’s updated interpretation of its authority to regulate CDS as more such products from all over the world are released in the U.S., including how manufacturers of currently marketed products should adapt to ensure they remain compliant.
Suzanne Levy Friedman advises medical device companies on a wide range of activities across the life cycle of their products, including evaluating regulatory pathways, preparing submissions for FDA clearance or approval of new devices, advertising and promotion, and post-market product modifications. She focuses much of her practice on FDA's evolving paradigm for regulating software and digital health products, and she has helped clients determine whether they are regulated as the policies have shifted, and if so, how to appropriately bring their products to market. Suzanne also frequently works on human tissue and combination products that combine a medical device element with a drug or a biologic. In conjunction, she helps advise clients on regenerative medicine and cell/gene therapies, which often raise questions that touch on multiple areas of FDA regulation
Q-Lingua Translation & Content Services
12:20 - 12:40
How to Successfully Launch a Medical Device Globally - Best Practices in Combining between Language, Technology and People
Successful launch of a medical device in global markets is a task that involves many elements. Correctly engaging with the target market is a crucial success factor, and language is at the core of the go-to-market strategy. We will share a few tips, ideas and elements - of how to best utilize ever-developing technology tools, AI, and professional human experts - to reach a seamless, time and cost-saving process - while meeting all regulatory requirements.
Batia, CEO and Co-Founder of QMED-Lingua, the Life Sciences division of Q-Lingua, has more than 14 years’ experience in consulting medical device, health and other organizations on optimization of language and culture related strategies, incorporating synergy between the highest professional standards, ISO17100 compliance and technology – to elevate the outcomes of each MedTech organization. She holds an MBA, with more than 15 years’ experience in international business development and entrepreneurship in local and global companies, as well as serving as a strategic business consultant
Sector Manager Healthcare & Government
12:40 - 13:00
The Healthcare Revolution – How Technology and AI is Disrupting and Improving Patient Care
Challenges and changes in the Healthcare landscape
How AI can transform Digital Health
Responsible AI principles ensuring health equality and improving patient care.
13:00 - 14:00 : Lunch, Exhibit Viewing
Chief Digital Transformation Officer
Sheba - Tel HaShomer City Of Health
14:00 - 14:20
From A House for the Sick To A city of Health
What will the hospitals look like in about ten years? How are we preparing to deal with the expected increase in demand for health services compared to the lack of resources?
The hospitals will have to undergo a transformation, in order to provide better and more advanced healthcare services.
How the transition from a hospital concept to a city of health answers the challenges of the future.
Mr. Benny ben lulu is A Well Experienced IT professional with Extensive knowledge of digital health
develops and implements Sheba's digital transformation strategy
developed the cloud strategy for Sheba
managed complex projects in healthcare related to information technology and digital transformation
has extensive experience with medical imaging technology
expert at rethinking processes and putting new ideas into practice
14:20 - 14:40
Clinical Intake Needs an Evolution: Here’s How Explainable AI Can Help
Big-data-driven self-assessment tools have gained momentum and popularity with patients. But so far, such tools haven’t eased the burden healthcare providers are experiencing because of AI’s “black box” problem. AI’s “black box” problem within the medical community means an algorithm gets an input and gives an output, without showing how the process took place. AI with a “black box” is difficult to trust since it’s unknown how the AI reaches its conclusion and therefore doctors can’t evaluate the process.Additionally, assessment tools are designed to be used by patients rather than physicians making diagnoses. In order for AI to be adopted within the medical community, it needs to be able to show where it’s getting information from instead of just doing statistical inference.
Dr. Michal Tzuchman-Katz is the Co-Founder and Chief Medical Officer at Kahun Medical. Prior to joining Kahun in 2018, Dr. Tzuchman-Katz worked as a Pediatrician at Clalit Health Services, the largest HMO in Israel. In addition to her leadership role at Kahun Medical, Dr. Tzuchman-Katz practices emergency medicine in Pediatric ED at Ichilov Sourasky Medical Center, where she has also completed her medical residency. Dr. Tzuchman-Katz also comes from a background of software engineering and has led a tech development team at Live Person.
Dr. Michal Tzuchman Katz
Co-Founder and Chief Medical Officer
14:40 - 15:00
Innovation at Tel Aviv Medical Center
Tel Aviv Sourasky Medical Center (Ichilov)
The Ichilov Hospital located in the center of Tel Aviv brings together the best doctors and the best technologies available in the world.
In this lecture, some of the breakthrough technologies will be presented and we will discuss their impact on the lives of patients and visitors to the medical center.
Gilat Schreiber is the CTO of Tel Aviv Sourasky medical center (Ichilov) responsible for locating and implementing various innovative technologies.
Gilat has over 20-year experience in medical devices holding various positions: from R&D and engineering, to business development and running a companies as CEO. Gilat holds a BSC in biomedical engineering and an MBA, both from Ben Gurion University.
15:00 - 15:30
Panel Discussion - Digital Healthcare – Experts Panel
Moshe Klaiman, CEO, Matrix Medika
Gilat Schreiber, CTO, Tel Aviv Sourasky Medical Center (Ichilov)
Lior Tzioni, Sector Manager Healthcare & Government, Microsoft Israel
TBD - additional experts!